A novel approach for quantification of KIR expression in healthy donors and pediatric recipients of hematopoietic SCTs

Bone Marrow Transplantation

Volumn 43, Issue 7, 2009, Pages 525-532

  Chen, X ^a   Knowles, J ^a   Barfield, R C ^a   Kasow, K A ^a   Madden, R ^a   Woodard, P ^a   Srivastava, D K ^a   Horwitz, E M ^a   Handgretinger, R ^a   Hale, G A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; FEMALE; GENOTYPE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; NONHODGKIN LYMPHOMA; ORGAN DONOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KILLER CELLS, NATURAL; LEUKEMIA; MALE; RECEPTORS, KIR; TISSUE DONORS;

EID: 64949148653     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.352     Document Type: Article

References (17)

1. Carrington M, Martin MP. The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol 2006; 298: 225-257.
2. Vilches C, Parham P. KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20: 217-251.
3. Borrego F, Kabat J, Kim DK, Lieto L, Maasho K, Pena J et al. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 2002; 38: 637-660.
4. Ruggeri L, Capanni M, Mancusi A, Martelli MF, Velardi A. The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. Transpl Immunol 2005; 14: 203-206.
5. Koenecke C, Shaffer J, Alexander SI, Preffer F, Dombkowski D, Saidman SL et al. NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CE2mAB, Medi-507. Exp Hematol 2003; 31: 911-923.
6. Gagne K, Brizard G, Gueglio B, Milpied N, Herry P, Bonneville F et al Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 2002; 63: 271-280.
7. Bignon JD, Gagne K. KIR matching in hematopoietic stem cell transplantation. Curr Opin Immunol 2005; 17: 553-559.
8. Dupont B, Hsu KC. Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in hematopoietic stem cell transplantation. Curr Opin Immunol 2004; 16: 634-643.
9. Leung W, Iyengar R, Turner V, Lang P, Bader P, Conn P et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol 2004; 172: 644-650.
10. Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K et al Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 2005; 105: 4878-4884.
11. Keller MD, Chen DF, Condron SA, Liu N, Reinsmoen NL, Buckley RH. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency. J Clin Immunol 2007; 27: 109-116.
12. Leung W, Iyengar R, Triplett B, Turner V, Behm FG, Holladay MS et al Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 2005; 174: 6540-6545.
13. Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003; 101: 3730-3740.
14. Denis L, Gagne K, Gueglio B, Kendudou N, Milpies N, Simon P et al. NK-KIR transcript kinetics correlate with acute graftversus-host disease occurrence after allogeneic bone marrow transplantation. Hum Immunol 2005; 66: 447-459.
15. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc 1995; 57: 289-300.
16. Garcia CA, Robinson J, Guethlein LA, Parham P, Madrigal JA, Marsh SG. Human KIR sequences 2003. Immunogenetics 2003; 55: 227-239.
17. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trend Immunol 2001; 22: 633-640.